ESG

With $60M in public funds and a $120M investment, Xplore aims to connect over 70,000 underserved homes to 500 Mbps speeds, reshaping rural life.

A $12M deal for natural gas fuel systems signals a major shift from diesel in Mexico's trucking industry, promising huge cost and emissions savings.

A new partnership shows how data-driven onsite health centers are slashing hospital bills and improving patient outcomes, offering a new playbook for employers.

After flawless human trials, a Chapel Hill startup secures funding to bring its revolutionary ultrasound-based blood clot treatment to the United States.

New online communities offer an 'emotional prescription' for patients, but can the platform's 'gold standard' model balance support with business?

Memphis-based Barr Brands marks 80 years of innovation and 30 years as a 100% employee-owned company, a model for longevity and shared success.

As fraudulent hospice claims top $3 billion, a new private certification program hopes to restore trust and protect vulnerable end-of-life patients.

Ever.Ag's Feedlot IQ, an AI-powered platform, aims to revolutionize cattle management by unifying data for earlier health detection and improved efficiency.

The tech giant's recent accolades for innovation, ethics, and leadership hint at a future where AI is both powerful and responsible for nonprofits.

EP Wealth adds $390M AUM by acquiring Santa Fe's LongView, a B Corp leader, blending its national growth strategy with a deep commitment to ESG.

As millions face losing healthcare, AI startup Graici has secured $7.5M to automate Medicaid renewals, betting its data wallet can solve a national crisis.

In a new digital arms race, Dashlane's AI Scam Protection analyzes websites in real-time to stop phishing before you even enter your sensitive data.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

With a key drug for a rare disease nearing the finish line, Spruce adds two industry veterans to navigate the high-stakes FDA approval process.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Omilia has launched a self-learning AI platform promising 'zero-day go-live' for autonomous agents, challenging the entire customer service industry.

New Medicare rules expand access to opioid alternatives, reshaping post-surgery recovery and rewarding companies at the forefront of pain management.

As AI data centers strain power grids, a tiny new component from Microchip promises to boost power density and efficiency, fueling the next wave of computing.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.